Microbot Medical (NASDAQ:MBOT) Releases Earnings Results, Misses Expectations By $0.02 EPS

Microbot Medical (NASDAQ:MBOT) announced its quarterly earnings data on Tuesday. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.02), Zacks reports.

Microbot Medical Trading Down 0.6 %

Shares of MBOT traded down $0.01 during mid-day trading on Tuesday, hitting $1.59. The company’s stock had a trading volume of 759,689 shares, compared to its average volume of 1,767,746. The company’s 50-day moving average is $1.75 and its 200-day moving average is $1.30. Microbot Medical has a 52-week low of $0.82 and a 52-week high of $3.38. The firm has a market capitalization of $55.24 million, a price-to-earnings ratio of -1.99 and a beta of 1.60.

Analyst Upgrades and Downgrades

Separately, HC Wainwright raised their price target on Microbot Medical from $7.00 to $9.00 and gave the company a “buy” rating in a research note on Friday, January 24th.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.